Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/7/2025

Medications for Sciatica: Evidence-Based Treatment Approach

First-Line Pharmacological Treatment

  • The American College of Physicians recommends continuous NSAID treatment over on-demand dosing for inflammatory back conditions including sciatica, though the evidence quality is low 1
  • NSAIDs showed a risk ratio of 1.14 (95% CI 1.03-1.27) for global improvement versus placebo, but no significant pain reduction (MD -4.56, 95% CI -11.11 to 1.99) 2
  • Meloxicam dosing is 7.5-15 mg once daily (standard COX-2 selective NSAID dosing) 1
  • Naproxen dosing is 500 mg twice daily 3
  • Ibuprofen dosing is 400-800 mg three times daily 4

Second-Line: Add Neuropathic Pain Agents

  • Gabapentin is particularly effective for radicular pain/sciatica with small to moderate short-term benefits for radiculopathy 2
  • The American College of Physicians recommends adding gabapentin or pregabalin to target the neuropathic component of sciatica for patients with inadequate response to NSAIDs alone 2

Third-Line: Tricyclic Antidepressants

  • Tricyclic antidepressants provide moderate pain relief for chronic low back pain with good evidence supporting efficacy 2
  • Amitriptyline dosing starts at 10-25 mg at bedtime, with titration by 10-25 mg weekly as tolerated, and a target dose of 50-75 mg at bedtime 2

Adjunctive Therapy for Acute Exacerbations

  • Cyclobenzaprine dosing is 5-10 mg three times daily for maximum 2-3 weeks 3, 2
  • Tizanidine dosing is 2-4 mg three times daily, can increase to 8 mg three times daily 3
  • Tramadol dosing is 50-100 mg every 4-6 hours as needed, with a maximum of 400 mg/day 5

Medications to AVOID

  • Systemic corticosteroids are NOT recommended for sciatica—three higher-quality trials consistently found no clinically significant benefit compared to placebo 3, 5, 2
  • Opioids should be avoided due to limited evidence for short-term modest effects with significant risks including constipation, sedation, nausea, and potential for abuse/addiction 4, 2
  • Benzodiazepines are ineffective for radiculopathy based on low-quality evidence and carry risks of abuse, addiction, and tolerance 2

Critical Monitoring Parameters

  • NSAIDs require monitoring for gastrointestinal bleeding, cardiovascular events, and renal dysfunction, especially with long-term use 1
  • Gabapentin/Pregabalin require monitoring for sedation, dizziness, peripheral edema; adjust dosing in renal impairment 2

Management of Sciatica Pain with Naproxen

Treatment Duration

  • An adequate trial period requires at least 8 weeks for full NSAID effect, given the time course to response of about 1 month, as reported in The Lancet Child and Adolescent Health 6